Holen Sie sich die Stockscreener-App
1.10
0.92%
0.01
Schlusskurs vom Vortag:
$1.09
Offen:
$1.095
24-Stunden-Volumen:
21,431
Relative Volume:
0.29
Marktkapitalisierung:
$9.59M
Einnahmen:
$6.74M
Nettoeinkommen (Verlust:
$-14.74M
KGV:
-0.4891
EPS:
-2.2491
Netto-Cashflow:
$-18.31M
1W Leistung:
+3.77%
1M Leistung:
-7.17%
6M Leistung:
-51.33%
1J Leistung:
-23.61%
1-Tages-Spanne:
$1.0655
$1.10
1-Wochen-Bereich:
$1.05
$1.19
52-Wochen-Spanne:
$0.95
$2.42
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.10 | 9.50M | 6.74M | -14.74M | -18.31M | -2.2491 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Investment Recap: Is Evogene Ltd stock a smart buy before Fed meetingTrade Entry Report & Free Growth Oriented Trading Recommendations - BỘ NỘI VỤ
Evogene (NASDAQ:EVGN) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
How AI Is Breaking Down the Bottlenecks in Small Molecule Drug Discovery - Unite.AI
Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Fincantieri SpA 1F80 Stock Analysis and ForecastHead and Shoulders Patterns & Fast Profit Portfolio Plans - earlytimes.in
Will Evogene Ltd. stock keep outperforming rivalsEarnings Performance Report & Accurate Technical Buy Alerts - BỘ NỘI VỤ
12 Health Care Stocks Moving In Friday's After-Market Session - Sahm
Evogene (NASDAQ:EVGN) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL (PR Newswire) - Aktiellt
Evogene shares climb 5% as cost reductions help deliver earnings beat - MSN
Evogene Ltd. Reports Strategic Shift and Financial Results - MSN
Evogene Ltd. Earnings Call: Strategic Shifts and Optimism - The Globe and Mail
Is Evogene Ltd. stock cheap compared to fundamentals - newser.com
Evogene Ltd. (NASDAQ:EVGN) Q3 2025 Earnings Call Transcript - Insider Monkey
Can Evogene Ltd. stock hit record highs again2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
Is Evogene Ltd. stock oversold or undervalued2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
Evogene: Q3 Earnings Snapshot - Stamford Advocate
Evogene earnings beat by $0.12, revenue fell short of estimates - Investing.com Australia
Evogene Q3 2025 Earnings Call Transcript - MarketBeat
Earnings Call Summary | Evogene(EVGN.US) Q3 2025 Earnings Conference - 富途牛牛
Earnings call transcript: Evogene reports Q3 2025 earnings beat amid restructuring - Investing.com India
Evogene shares rise 5% as cost-cutting measures drive earnings beat - Investing.com Nigeria
Evogene Reports Third Quarter 2025 Financial Results - The AI Journal
Evogene Reports Q3 2025 Financial Results Amid Strategic Shift - TipRanks
Israeli biotech firm Evogene's Q3 revenue misses estimates due to reduced seed sales - TradingView
Evogene shares rise 5% as cost-cutting measures drive earnings beat By Investing.com - Investing.com South Africa
Evogene : Q3 2025 Consolidated Financial Statements - MarketScreener
[6-K] Evogene Ltd. Current Report (Foreign Issuer) | EVGN SEC FilingForm 6-K - Stock Titan
Will Evogene Ltd. stock outperform international peers2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Evogene Ltd. stock maintain growth storyMarket Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
[EFFECT] Evogene Ltd. SEC Filing - Stock Titan
Is Evogene Ltd. stock a buy for dividend growthJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - newser.com
How strong is Evogene Ltd. stock revenue growthCEO Change & Free Community Consensus Stock Picks - newser.com
Evogene Ltd. stock prediction for this weekGDP Growth & Weekly Top Gainers Trade List - newser.com
What technical models suggest about Evogene Ltd.’s comeback2025 Performance Recap & Reliable Intraday Trade Plans - newser.com
What's Next: Evogene's Earnings Preview - Benzinga
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):